Coming Soon: Important OCE/IVE Updates
Published Date: July 25, 2025
New name, same trusted guidance.
OCE and IVE sheets will soon be known as Patient Education Sheets — clearer, more consistent, and still rooted in the expert-backed information you rely on.
For years, clinicians and patients alike have trusted our Oral Chemotherapy Education (OCE) and Intravenous Cancer Treatment Education (IVE) sheets for straight-forward, evidence-based guidance. We’re excited to launch the updated Patient Education Sheets later this summer, offering important enhancements in a format that’s even easier to read, share, and understand.
Stay tuned for more updates as we roll out this meaningful transition later this summer.
Learn More on Patient Education Sheets Rebrand, Coming Soon!
Patient Education Sheets: Committees and Responsibilities
Members
ACCC
- Meagan O’Neill
- Reesa Sherin
HOPA
- Anne Krolikowski
NCODA
- Michael Reff
- Michelle Taymuree
ONS
- Brenda Nevidjon
- Erica Fischer-Cartlidge
Team Roles and Responsibilities
- Appoint respective organization’s members to Review Committee.
- Provide strategic oversight and guidance to the Review Committee, including decisions on expansion or reduction of the project and Review Committee scope.
- Attend a minimum of three (3) meetings annually.
Members
ACCC Representatives
- Jiajoyce Richardson, DNP; Penn State Health
- Una Hopkins, DNP; Montefiore Health System
HOPA Representatives
- Laura Nice, PharmD, BCOP; Allegheny Heath Network
- Jennifer Niccolai Martin, PharmD, BCOP; Allegheny Heath Network
NCODA Representatives
- Tahsin Imam, PharmD; NCODA
- Kelly Brunk, PharmD, BCOP; NCODA
ONS Representatives
- Madeline Johnston, MSN, RN, OCN; ONS
- Kristine LeFebvre, DNP, RN, NPD-BC, AOCN; ONS
Team Roles and Responsibilities
- Review each sheet within 5 business days.
- Ensure education sheets reflect the latest FDA-approved product information and guidelines.
- Meet quarterly, or as needed, for discussion and review of submitted questions.
- Review and update templates for education sheets every 12-18 months.
- Share updates, feedback, and concerns with the executive representative on the Executive Leadership Team as needed.
Committee Makeup:
Chair: Marie Sirek, PharmD, BCACP, CPP; Billings Clinic
Vice Chair: Megan Tran, PharmD; Prisma Health
NCODA Liaisons:
- Tahsin Imam, PharmD; NCODA
- Kelly Brunk, PharmD, BCOP; NCODA
- Kristen Bertonazzi, MBA; NCODA
Members
Advanced Practice Providers
- Lindsey Garnett, Endeavor Health
- Linda Ippolito, Loyola Medical Center
Nurses
- Kinjal Patel, Florida Cancer Specialists & Research Institute
- Jennifer Sassano, Texas Oncology
- Jennifer Lewellyn, Asante
- Billie Matlock, Sanford Health
- Jennifer VanFleet, Clearview Cancer Institute
- Adrian Branch, HCA
Pharmacists
- Nicholas Bitz, University Hospitals
- Kristina Hazard, Kaiser Permanente
- Katie Tobon, Mofitt Cancer Center
- Jessica McKernan, University of Wisconsin Health
- Shelbie Gibbs, The University of Kansas Health System
- Michelle Phillips, University of Rochester Medical Center
- Richa Madurkar, OncoHealth
- Chelsey Lindner, Shields Health Solutions
- Rachel Siu, Moffitt Cancer Center
- Kateryna Kovalenko, Moores Cancer Center at University of San Diego
- Morgan Corbin, Novant Health Zimmer Cancer Institute
- Lindsey Jung, William S Middleton Veterans Hospital and Clinics
Team Roles and Responsibilities
- Transition legacy documents (i.e., existing Oral Cancer Treatment Education (OCE), Intravenous Cancer Treatment Education (IVE), Combination IV and Oral Cancer Education Sheets, and Supplemental Sheets) to Patient Education Sheets (PES).
- Propose new educational sheets based on identified gaps and emerging practices.
- Ensure all sheets are patient-friendly and contain accurate information.
- Coordinate reviews and approvals with the NCODA clinical liaisons.
- Develop a framework for recording educational videos, simulating patient counseling sessions.
NCODA liaison
- Serve as advisor to Chair and Vice Chair
- Support the review, revision, and approval processes for PES and related resources.
- Help coordinate the development and dissemination of PES materials and new resources.
- Assist in monitoring and evaluating the clarity, effectiveness, and patient understanding of PES.
- Contribute to the organization and management of project timelines and milestones.
PES Committee Members
- Review, update, and convert at least one (1) legacy document into the new PES template each month (excluding December).
- Review and provide feedback on at least one (1) PES developed by another committee member each month (excluding December).
- Promote the use and integration of PES within relevant clinical settings.
- Attend scheduled committee meetings and actively participate in discussions.
- If unable to attend a meeting, watch the recorded session and submit confirmation survey within 14 days.
- Submit requests for new PES development or revisions to existing sheets as needed to improve clarity and accuracy.
- Take on specific projects or initiatives as assigned by the Chair to support the development and implementation of PES.
- Provide constructive feedback and suggestions to enhance the quality and relevance of PES materials.
- Stay informed about updates, new resources, and best practices related to patient education.
Kelly serves as the NCODA clinical pharmacist is responsible for creating, maintaining, and updating the cancer education sheets, ensuring their clinical accuracy and alignment with the latest FDA-approved labels and evidence. They incorporate feedback from the review committee but have the authority to make final edits and approve the content for publication. Additionally, they oversee the quality control of the educational materials and facilitate their dissemination through the project’s digital platforms.
Kristen serves a project manager overseeing the review process, manages timelines, coordinates meetings, ensures compliance with procedures, and facilitates the final formatting and publication of the education sheets.